论文信息 - A Phase I Study of PF-04929113 (SNX-5422), an Orally Bioavailable Heat Shock Protein 90 Inhibitor, in Patients with Refractory Solid Tumor Malignancies and Lymphomas - 字舞流文

A Phase I Study of PF-04929113 (SNX-5422), an Orally Bioavailable Heat Shock Protein 90 Inhibitor, in Patients with Refractory Solid Tumor Malignancies and Lymphomas

G. Giaccone | W. Zein | B. Houk | J. Trepel | S. Kummar | W. Figg | M. Shnaidman | A. Rajan | R. Kelly | M. Gutierrez | B. Mannargudi | N. Brega | Y. Kim | S. Alarcon | S. Crandon | Lokesh Jain